Skip to main content

London, UK Gel Injections For Knee Osteoarthritis: Surgery Alternative Announced

MSK Doctors, (+44 033 0001 0048) a leading UK-based network of musculoskeletal specialists, announces a revolutionary gel injection called Arthrosamid, a safe, minimally invasive alternative to surgery that delivers long-lasting knee pain relief for individuals suffering from osteoarthritis.

-- Recently announced Arthrosamid treatments from MSK Doctors offer a unique treatment option for knee osteoarthritis by adhering to the synovial membrane, the soft tissue lining of the knee joint. Acting as a scaffold for tissue regeneration, the gel enhances the thickness of the synovial fluid, reducing stiffness, improving mobility, and providing significant pain relief. Unlike steroid injections that offer only short-term benefits, Arthrosamid has demonstrated the ability to provide results lasting two years or longer.

More information is available at https://mskdoctors.com/treatments/arthrosamid

The clinical efficacy of Arthrosamid has been validated by multiple studies, including a 52-week prospective study published in the Journal of Orthopaedic Surgery & Research that reported notable improvements in pain, stiffness, and function. Additional research has confirmed the gel’s safety profile, with no long-term adverse effects, solidifying its position as a promising solution for knee osteoarthritis management, and comparative data has also shown Arthrosamid’s superior performance over traditional treatments, such as hyaluronic acid injections.

“Arthrosamid represents a true breakthrough in the treatment of knee osteoarthritis,” says Professor Paul Lee, MBBch, MFSEM (UK), MSc (Sports Med), PhD, FEBOT, FRCS (T&O) consultant orthopaedic surgeon and founder of MSK Doctors. “Its unique mechanism not only alleviates symptoms but also supports tissue regeneration, offering patients an effective and lasting alternative to invasive procedures.”

Real-world applications of Arthrosamid further highlight its transformative potential. Among its notable success stories is the case of an Olympic athlete who reported significant pain relief and improved mobility, enabling them to compete at peak performance. Similarly, a leading Harley Street GP shared how the treatment restored their quality of life, allowing them to resume their demanding daily activities pain-free.

As knee osteoarthritis remains a major health concern worldwide, Arthrosamid is poised to redefine the standard of care for patients seeking long-term relief. MSK Doctors encourage those experiencing persistent knee pain and hoping to avoid surgery to consult with a specialist to determine if Arthrosamid is a suitable option.

A recent patient says, "I am extremely satisfied with the results of my Arthrosamid knee injection. I have been pain-free for weeks and have full range of motion. I highly recommend this treatment to anyone suffering from knee pain."

Appointments with an MSK specialist, including Prof. Paul Lee, can be scheduled with no waiting list and no GP referral, using the MSK Doctors website. Learn more by visiting https://mskdoctors.com

Contact Info:
Name: Bethan Lee
Email: Send Email
Organization: MSK Doctors
Address: MSK House London Road Silk Willoughby, Sleaford, Lincolnshire, Sleaford, England NG34 8NY, United Kingdom
Website: https://www.mskdoctors.com

Source: PressCable

Release ID: 89152531

Should you identify any discrepancies, concerns, or inaccuracies in the content provided in this press release or require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team is committed to addressing your concerns within 8 hours by taking necessary actions to resolve identified issues diligently or guiding you through the necessary steps for removal. Our dedication lies in providing accurate and reliable information.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.